Elisabetta Abruzzese

11.9k total citations
150 papers, 3.2k citations indexed

About

Elisabetta Abruzzese is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Elisabetta Abruzzese has authored 150 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Hematology, 84 papers in Genetics and 45 papers in Rheumatology. Recurrent topics in Elisabetta Abruzzese's work include Chronic Myeloid Leukemia Treatments (106 papers), Chronic Lymphocytic Leukemia Research (72 papers) and Eosinophilic Disorders and Syndromes (45 papers). Elisabetta Abruzzese is often cited by papers focused on Chronic Myeloid Leukemia Treatments (106 papers), Chronic Lymphocytic Leukemia Research (72 papers) and Eosinophilic Disorders and Syndromes (45 papers). Elisabetta Abruzzese collaborates with scholars based in Italy, United States and United Kingdom. Elisabetta Abruzzese's co-authors include Sergio Amadori, Marilina Amabile, Roberto Stasi, Gianantonio Rosti, Michele Baccarani, Paolo de Fabritiis, Giovanni Del Poeta, Fausto Castagnetti, Giovanni Martinelli and Simona Soverini and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elisabetta Abruzzese

136 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabetta Abruzzese Italy 27 2.5k 1.8k 1.1k 538 456 150 3.2k
Susanne Saußele Germany 30 3.0k 1.2× 2.4k 1.4× 1.4k 1.2× 579 1.1× 403 0.9× 127 3.5k
Laurence Legros France 30 3.6k 1.4× 2.7k 1.5× 1.5k 1.3× 681 1.3× 403 0.9× 126 4.1k
Franck E. Nicolini France 19 2.7k 1.1× 2.1k 1.2× 1.2k 1.1× 501 0.9× 256 0.6× 56 3.0k
Zbigniew Rudzki Australia 21 2.7k 1.1× 2.2k 1.3× 1.5k 1.4× 586 1.1× 308 0.7× 101 3.8k
Jaspal Kaeda United Kingdom 30 3.6k 1.4× 2.8k 1.6× 1.9k 1.7× 511 0.9× 468 1.0× 69 4.3k
Francesca Palandri Italy 30 2.4k 1.0× 2.2k 1.2× 1.2k 1.1× 293 0.5× 160 0.4× 180 3.2k
Jamshid S. Khorashad United Kingdom 24 2.4k 0.9× 2.1k 1.2× 1.2k 1.1× 304 0.6× 296 0.6× 67 2.9k
Charles Chuah Singapore 28 3.5k 1.4× 2.7k 1.5× 1.6k 1.4× 860 1.6× 447 1.0× 108 4.6k
Stephen G. O’Brien United Kingdom 23 3.8k 1.5× 3.1k 1.8× 2.1k 1.8× 663 1.2× 442 1.0× 43 4.5k
Juan Luis Steegmann Spain 20 1.9k 0.7× 1.6k 0.9× 929 0.8× 329 0.6× 220 0.5× 73 2.3k

Countries citing papers authored by Elisabetta Abruzzese

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Abruzzese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Abruzzese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Abruzzese more than expected).

Fields of papers citing papers by Elisabetta Abruzzese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Abruzzese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Abruzzese. The network helps show where Elisabetta Abruzzese may publish in the future.

Co-authorship network of co-authors of Elisabetta Abruzzese

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Abruzzese. A scholar is included among the top collaborators of Elisabetta Abruzzese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Abruzzese. Elisabetta Abruzzese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abruzzese, Elisabetta, Ekaterina Chelysheva, Delphine Réa, et al.. (2025). Asciminib and pregnancy in CML: Preliminary human data and clinical implications from 47 reported outcomes. Blood. 146(Supplement 1). 5566–5566.
2.
Costa, Alessandro Nanni, Elisabetta Abruzzese, Roberto Latagliata, et al.. (2024). Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of Clinical Medicine. 13(1). 273–273. 3 indexed citations
3.
Cortes, Jörge E., Elisabetta Abruzzese, Elyce Cardonick, et al.. (2024). Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding. Clinical Cancer Research. 30(17). 3658–3666. 2 indexed citations
4.
Gambacorti‐Passerini, Carlo, Tim H. Brümmendorf, Elisabetta Abruzzese, et al.. (2024). Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial. Leukemia. 38(10). 2162–2170. 2 indexed citations
5.
Abruzzese, Elisabetta, et al.. (2024). The Pregnant or Want-to-Be Pregnant CML Patient. Clinical Lymphoma Myeloma & Leukemia. 24. S16–S18. 1 indexed citations
6.
Pulsoni, Alessandro, Ombretta Annibali, Roberta Battistini, et al.. (2023). Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin’s disease. Frontiers in Oncology. 13. 1059393–1059393. 4 indexed citations
7.
Breccia, Massimo, Alfonso Piciocchi, Elisabetta Abruzzese, et al.. (2023). Italian Physicians’ Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey. Journal of Clinical Medicine. 12(16). 5267–5267. 1 indexed citations
8.
Muro, Marianna De, Sergio Amadori, Paolo de Fabritiis, et al.. (2023). Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy. Therapeutic Advances in Hematology. 14. 1564108443–1564108443.
9.
Abruzzese, Elisabetta, Malgorzata Monika Trawinska, & Paolo de Fabritiis. (2021). Chronic Myeloid Leukemia and Pregnancy: “Per Aspera Ad Astra”. Clinical Lymphoma Myeloma & Leukemia. 21. S153–S155. 3 indexed citations
10.
Claudiani, Simone, Dragana Milojković, Richard Szydlo, et al.. (2017). Changes in RT-qPCR Levels during and after TKI Interruptions for Attempted Conceptions in Women with CML. Blood. 130. 1612. 1 indexed citations
11.
Paquette, Ronald, Bengt Simonsson, Elisabetta Abruzzese, et al.. (2015). CARDIOVASCULAR (CV)-RELATED HOSPITALIZATION IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN SIMPLICITY, A PROSPECTIVE OBSERVATIONAL STUDY. Haematologica. 100. 437–437. 2 indexed citations
12.
Bocchia, Monica, Sara Galimberti, Antonella Gozzini, et al.. (2014). ATHEROTHROMBOTIC RISK ASSESSMENT DURING TYROSINE KINASE INHIBITORS TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: NEW INSIGHT?. Haematologica. 99. 533–534. 1 indexed citations
13.
Fratoni, Stefano, Pasquale Niscola, Elisabetta Abruzzese, et al.. (2013). Primary pulmonary Hodgkin Lymphoma simulating a mediastinal tumour: an uncommon occurrence.. Mediterranean Journal of Hematology and Infectious Diseases. 5(1). e2013013–e2013013. 3 indexed citations
14.
Defina, Marzia, Alessandro Gozzetti, Elisabetta Abruzzese, et al.. (2012). Evaluation of residual CD34+Ph+ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first‐line nilotinib therapy. Cancer. 118(21). 5265–5269. 10 indexed citations
15.
Stasi, Roberto, Nichola Cooper, Giovanni Del Poeta, et al.. (2008). Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab. Blood. 112(4). 1147–1150. 305 indexed citations
16.
Silvestri, Romano, Gabriella Marfè, Marino Artico, et al.. (2006). Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs):  A New Class of Agents with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Who Were Imatinib-Resistant. Journal of Medicinal Chemistry. 49(19). 5840–5844. 47 indexed citations
17.
Venditti, Adriano, Anna Tamburini, Francesco Buccisano, et al.. (2000). A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes. Annals of Hematology. 79(3). 138–142. 24 indexed citations
18.
Stasi, Roberto, Giovanni Del Poeta, Adriano Venditti, et al.. (1998). AML-M0: a biological and clinical profile. Cineca Institutional Research Information System (Tor Vergata University). 4. 181–198. 2 indexed citations
19.
Abruzzese, Elisabetta, et al.. (1998). Identification of BCR-ABL Fusion on Chromosome 9 by Fluorescence In Situ Hybridization in Two Chronic Myeloid Leukemia Cases. Cancer Genetics and Cytogenetics. 105(2). 164–167. 16 indexed citations
20.
Stasi, Roberto, Adriano Venditti, Giovanni Del Poeta, et al.. (1996). High-dose chemotherapy in adult acute myeloid leukemia: Rationale and results. Leukemia Research. 20(7). 535–549. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Saußele Breakdown of academic impact, for papers by Laurence Legros Breakdown of academic impact, for papers by Franck E. Nicolini Breakdown of academic impact, for papers by Zbigniew Rudzki Breakdown of academic impact, for papers by Jaspal Kaeda Breakdown of academic impact, for papers by Francesca Palandri Breakdown of academic impact, for papers by Jamshid S. Khorashad Breakdown of academic impact, for papers by Charles Chuah Breakdown of academic impact, for papers by Stephen G. O’Brien Breakdown of academic impact, for papers by Juan Luis Steegmann
Rankless by CCL
2026